Biography/Memoir

Psychedelic telemedicine has arrived…

After an online screening process, clients are set up with a nurse practitioner who determines dosing and takes a medical history… clients can proceed unguided after the second session, former clients said… many similar teleservices springing up, “They would say, ‘Thank you for sharing that with me.’ And that was what they said every time…

READ MORE
Biography/Memoir

Secret DEA files sell for just $5…

…had been selling the files for just $50, according to a search warrant and criminal charges filed in the trafficking investigation. Some government “paperwork” on a drug trafficking investigation in West Virginia was being leaked, including confidential information previously provided by the witness… Original Article (Forbes):Secret DEA files sell for just $5 on facebook – here’s how…

READ MORE
Biography/Memoir

Cannabis stocks… US federal legalisation…

The average US-listed cannabis stock is down by more than a third since the start of 2021, compared with 20 per cent for the S&P 500, while the Canadian cannabis index is down roughly 50 per cent over the same period. …marijuana legislation has failed to gain support in the Senate, including the Safe and…

READ MORE
Biography/Memoir

…psychedelic… 2022

…there’s a long way to go before these therapies are available to everyone. For one, many of the substances, including MDMA and psilocybin, will likely not get the legal green light for another few years, though some jurisdictions are leading the way. With one in five North Americans experiencing a mental illness in any given…

READ MORE
Biography/Memoir

…opioids devastation…

…lawyer pushed against extending protections for members of the family, which is worth billions: Joe Rice, a lead lawyer for local governments who had sued Purdue… Judge Robert Drain said that if a deal was not in place by [Feb. 17, 2022], “all bets are open” as to whether he would protect the family again.…

READ MORE
Biography/Memoir

[Ninth Circuit] federal appeals court dismisses ‘right-to-try’ psilocybin lawsuit by cancer patients

The lawsuit was filed against the DEA by three Seattle-based patients… The U.S. Court of Appeals for the Ninth Circuit has dismissed a lawsuit by cancer patients seeking to use psilocybin to treat end-of-life depression and anxiety… the plaintiffs argue that DEA’s position leaves no path forward for accessing psilocybin as an end-of-life treatment. Original Article (Ganjapreneur):Federal…

READ MORE
Biography/Memoir

…difference between [sclerotia galindoi truffles] microdosing & placebo, trial finds

…doses were made by the participants using dried [sclerotia galindoi] truffles… …did not find an effect of [sclerotia galindoi truffles] microdosing on interoceptive awareness, nor on emotion processing or symptoms of anxiety and depression… Original Article (New Atlas & Journal of Psychopharmacology): Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and…

READ MORE
Biography/Memoir

Marijuana companies urged governor to ban… home cultivation, document shows… [are psilocybin… companies doing the same?]

“From our perspective, it’s really hard to see any real reason – other than individual and corporate greed – to be against home cultivation at this point,” Erik Altieri, executive director of NORML… “There’s not a lot of rational concerns when it comes to allowing a limited amount of plants for an individual to grow at…

READ MORE